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Objective.—We investigated in a sham-controlled trial the analgesic effects of a 4-week treatment of transcranial direct
current stimulation (tDCS) over the primary motor cortex in chronic migraine. In addition, using a high-resolution tDCS
computational model, we analyzed the current flow (electric field) through brain regions associated with pain perception and
modulation.
Methods.—Thirteen patients with chronic migraine were randomized to receive 10 sessions of active or sham tDCS for 20
minutes with 2 mA over 4 weeks. Data were collected during baseline, treatment and follow-up. For the tDCS computational
analysis, we adapted a high-resolution individualized model incorporating accurate segmentation of cortical and subcortical
structures of interest.
Results.—There was a significant interaction term (time vs group) for the main outcome (pain intensity) and for the length
of migraine episodes (ANOVA, P < .05 for both analyses). Post-hoc analysis showed a significant improvement in the follow-up
period for the active tDCS group only. Our computational modeling studies predicted electric current flow in multiple cortical
and subcortical regions associated with migraine pathophysiology. Significant electric fields were generated, not only in targeted
cortical regions but also in the insula, cingulate cortex, thalamus, and brainstem regions.
Conclusions.—Our findings give preliminary evidence that patients with chronic migraine have a positive, but delayed,
response to anodal tDCS of the primary motor cortex. These effects may be related to electrical currents induced in pain-related
cortical and subcortical regions.
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pain
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Although migraine is a disorder characterized by
episodic attacks, some patients can develop a progres-
sive state of this disease with more than 15 attacks per
month. This state is referred to as chronic migraine
(CM). It has been shown that CM is not only a con-
dition associated with more frequent attacks but also
with changes in pain-related neural networks such
as increased sensitivity to noxious stimuli (hyperalge-
sia) and even non-noxious stimuli (allodynia, a phe-
nomenon that affects up to 63% of these patients).1-5
Furthermore, neuroimaging studies have shown that
development and perpetuation of migraine disorders
have a similar neural basis as the pathophysiology of
chronic pain.6 For instance, these imaging studies on
migraine found morphological and functional abnor-
malities in regions involved in central pain process-
ing, such as the trigeminal somatosensory pathway,
primary somatosensory cortex, and anterior cingu-
lated cortex.7 These results suggest that repeated
attacks can lead to central sensitization.6,8,9
Given evidence that chronic migraine is also
associated with central sensitization, one potential
therapeutic approach for these patients is the use of a
technique that can modulate pain-related neural net-
works such as transcranial direct current stimulation
(tDCS). This robust method of brain modulation has
demonstrated significant results in different types of
chronic pain,10-14 and has been shown to be more
effective at increasing pain tolerance than other
forms of transcranial stimulation.15 tDCS has poten-
tial advantages for the treatment of chronic pain dis-
orders, including its small portable size, low cost, and
ability to provide a more reliable placebo condition.16
In order to preliminarily investigate the analgesic
effects given our primary outcome of daily pain
measured by the visual analogue scale (VAS) of
an extensive 4-week tDCS treatment in chronic
migraine, 13 patients with CM were randomized to
receive active or sham stimulation of the primary
motor cortex. In addition, we used high-resolution
tDCS computational models to map the overall
pattern of (sub)cortical current flow using our param-
eters of stimulation, which may influence tDCS pain
treatment in a multimodal fashion.
METHODS
Study Subjects.—Our study consisted of a random-
ized, single-blinded with external blinded rater,17,18
placebo-controlled, proof of principle clinical trial.
The study conformed to the ethical standards of the
Helsinki Declaration (1964) and was approved by the
institutional ethics committee of Beth Israel Deacon-
ess Medical Center. All patients provided written
informed consent and the study took place at the
Noninvasive Center for Noninvasive Brain Stimula-
tion at Beth Israel Deaconess Medical Center.
Patients were referred from chronic pain clinics from
Boston such as the Arnold Pain Management Center
at Beth Israel Deaconess Medical Center. The study
included 13 participants between the ages of 18 and
60 years, diagnosed with chronic migraine by a pain
specialist according to the revised International
Headache Society Criteria (ICHD-II – appendix
1.5.1)19 with an established headache history occur-
ring on 15 or more days per month, however, for at
least 1 year, instead of only 3 months as defined in the
IHS guidelines. Patients with other neuropsy-
chiatric or pain disorders were excluded, and they
were instructed to maintain their regular preventive
therapy during the trial.
Assessments.—Participants were randomized to 2
different groups – sham or active tDCS – using a
simple randomization method. Baseline evaluation
was performed 1 week before the study. Participants
were assessed with self-report questionnaires and
investigator-guided questionnaires. The primary
outcome was perception of daily pain measured by
the VAS. The other reported secondary outcomes
included: length of migraine episodes, Patient Global
Assessment (PGA), and Clinical Global Impression
(CGI). In addition, safety was measured with an
adverse effects checklist, Mini-Mental State Exami-
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nation (MMSE) and Digit Span (forward and back-
ward) (these last 2 instruments were used to index
any detrimental effect on general cognitive function).
For baseline data, we measured all outcomes for one
full week immediately before the start of the trial in
order to have a reliable baseline assessment. Mea-
surements during treatment occurred at the midpoint
(T15) and end of treatment (T30).
Finally, follow-up measurements were conducted
at 60 (F60) and 120 (F120) days after the end of
treatment. For the measurements, we collected daily
data such as VAS pain, and averaged the periods of
treatment (for instance, T15 indicates T1 to T15).
Transcranial Direct Current Stimulation.—
Treatment was performed by an independent and
trained investigator who had no knowledge of the
subjects’ group assignment. Subjects received a total
of 10 sessions over a 4-week period (administered
every other day during weekdays (Mo-Wed-Fri/Tue-
Thu/Mo-Wed-Fri/Tue-Thu – over the course of 4
weeks) of either active or sham tDCS. The strategy of
every other day treatment was chosen as to be able to
give the treatment during a full month without being
unfeasible (having patients coming daily would make
the visits unfeasible for many patients). We have used
this strategy successfully in other studies.20
During each session, the anode electrode
(5 cm ¥ 7 cm) was placed over the motor cortex (con-
tralateral to the most [or predominant] painful side or
the side where the symptoms begin) and the cathode
electrode (5 cm ¥ 7 cm) was placed over the contralat-
eral supraorbital area. We chose this area based on
previous results in tDCS trials in chronic pain.10-14 In
addition, the majority of studies do unilateral stimula-
tion regardless whether pain is bilateral such as in
fibromyalgia and spinal cord pain.10,21-24 In fact, effects
of unilateral stimulation on pain in these studies are
observed bilaterally. In active tDCS subjects, 2 mA of
tDCS (Magstim, UK) was applied for 20 minutes. For
sham-controlled tDCS subjects, the same montage was
used; however, current was applied only for 30
seconds,which successfully prevents subjects from dis-
tinguishing it from active tDCS.16 The reason that
tDCS offers a reliable sham method is that it uses a
weak current (intensity of 2 mA) that is therefore
usually below the skin threshold for perception –
especially when applied continuously. Subjects often
feel during current ramp up; for this reason, tDCS is
offered during the first 30 seconds in the sham stimu-
lation instead of no current. Thirty-second stimula-
tion period is insufficient to produce meaningful
changes25,26 but mimics the initial sensation associated
with active stimulation. This method of blinding is
effective according to a recent study from the National
Institutes of Health16 and discussed in 3 recent
reviews.17,18,27 In addition, patients were naive to tDCS.
For further details about the tDCS protocol in
this study, the method is visually explained in a step-
wise manner by our scientific team in DaSilva et al.28
Statistical Analysis.—For statistical analysis, we
assume that missing data were at random. We, there-
fore, performed the outcome investigation using
intention-to-treat analysis with the method of last
observation carried forward (for patients who started
the treatment and received at least 1 session). We
considered the average of values collected in the
migraine diary (daily measurements) for baseline,
T15 (middle of treatment), T30 (final day of treat-
ment), F60 (first follow-up), and F120 (final follow-
up) (see Fig. 1). Statistical analysis was conducted
using STATA 11.0 (College Station, TX, USA). Ini-
tially, for continuous outcomes, as data are normally
distributed (using Shapiro-Wilk test), we conducted a
group analysis running a mixed ANOVA model in
which the independent variables were time, condition
of stimulation (sham vs active), the interaction term
time vs the condition, and subject ID. If appropriate,
we then performed post-hoc analysis using paired
t-test to assess effects of each condition of stimula-
tion. We did not correct for multiple comparisons as
this was an exploratory proof-of-principle study.
Finally, for ordinal outcomes (CGI and PGA), we
performed the analysis using a Kruskal-Wallis test.
High-Resolution Computational Model.—Using a
finite element (FE) model,29,30 we further analyzed
the effect of our electrode montage on the current
flow in the brain, taking into consideration the elec-
trical properties of cortical and subcortical structures.
The human head model was derived from a high-
spatial resolution (1 mm3) 3T magnetic resonance
imaging (MRI) of a male adult healthy subject, and
segmented into compartments representing the scalp,
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skull, cerebrospinal fluid, eye region, muscle, gray
matter, white matter, and air, respectively. In addition
to analyzing current flow patterns through structures
implicated in pain matrix processing, subcortical and
brain stem structures like insula, cingulate, thalamus,
midbrain, pons, medulla oblongata were also seg-
mented (Custom Segmentation, Soterix Medical,
New York, NY, USA). Since the head model was
directly derived from the MRI acquisition volume, it
was limited by the anatomical sections collected.
Thus, a synthetic dummy neck and shoulder region
was fused onto the existing segmented head.22,29
Sponge-based electrode stimulation pads (5 cm ¥
7 cm) were imported as computer-aided design
(CAD) models and placed onto the segmented head
to mimic the clinically used montage: anode electrode
over the motor cortex and the cathode electrode at
the forehead above the contralateral orbita. From the
segmented data, volumetric mesh was generated and
exported to an FE solver (COMSOL Multiphysics
3.5a, COMSOL Inc., Burlington, MA, USA). The fol-
lowing isotropic electrical conductivities (in S/m)
were assigned: scalp – 0.465; skull – 0.01; cerebro-
spinal fluid – 1.65; eye region – 0.4; muscle – 0.334;
gray matter – 0.276; white matter – 0.126; air – 1e-15;
synthetic region – 0.17; sponge – 1.4; electrode – 5.8e7.
The cingulate cortex, insula, and the thalamus were
assigned gray matter conductivity while the midbrain,
pons, and the medulla oblongata were assigned white
matter conductivity. The Laplace equation was
solved, and current density corresponding to 2 mA
total current was applied. Induced cortical surface
electric field (EF) magnitude and directional surface
(showing inward and outward cortical currents) were
determined (Fig. 3). In addition, cross-section magni-
tude plots were generated by plotting EF magnitude
on axial slices through the different subcortical and
brain stem regions (Fig. 4). Finally, it is important to
note that the head model does not capture functional
changes (unlike functional [f]MRI) and is based on
simple physical assumptions such as Ohm’s law.
Nevertheless, we expect that the novel and intriguing
prediction of current flow through deep brain struc-
tures is robust across subjects, and this general finding
must be taken into account in future work on tDCS as
well.
Fig 1.—Protocol design and method of time-points assessed during the protocol.
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RESULTS
Demographic Data and Adverse Effects.—
Thirteen individuals were included in this study (9
women; mean age of 45.8 years [6.3] ), with 8
patients randomized to the active group and 5
patients to the placebo group as we used a simple
randomization method. Demographic characteristics
are described in Table 1 (there were no significant
differences between sham and active tDCS groups).
There were no severe adverse effects. We reported
adverse effects in Table 2. Frequency of adverse
effects was not significantly different between the 2
groups of stimulation. Also, there was no significant
difference in the general cognitive assessment
(MMSE and digit span) comparing the 2 groups of
stimulation.
Clinical Effects of tDCS Over the Motor Cortex.—
Mixed ANOVA revealed a significant interaction
effect (between time and condition) for both VAS
pain and length of migraine episodes (F(8,44) = 2.46,
P = .02 for pain intensity and F(8,44) = 2.49, P = .02
for length of migraine episodes) but no significant
changes for level of anxiety. We then conducted post
hoc testing initially for VAS pain comparing baseline
vs other time-points.This analysis for the active tDCS
group revealed no significant change in pain intensity
at the first time-point T15 (t-test, P = .9) and a trend
for significance at the second time-point T30 (t-test,
P = .12) and F60 (t-test, P = .06). We then found a
significant decrease in pain levels at the last follow-up
– after 4 months (t-test, P = .03). In fact, pain levels
continued to decrease after the end of treatment
(Baseline = 4.6 (2.1); T15 = 4.7 (2.7); T30 = 3.7
(2); F60 = 3.1 (2.7); F120 = 2.9 (2.9) – see Fig. 2).
There was a similar result for length of migraine epi-
sodes showing a trend for significant improvement at
the T30, F60, and F120 (t-test, P = .2 for T30; P = .17
for F60; and P = .05 for F120), and also a decrease
in the absolute values for this variable across time
(length of migraine attacks (in hours) = baseline = 8
(8.5); T15 = 4.7 (7.9); T30 = 5 (7.9); F60 = 4.3
(6.4); F120 = 0.9 (1.1)). For the analysis of CGI
efficacy and improvement, statistical results revealed
no differences at T15 but a significant difference at
T30 for both CGI efficacy and improvement
(Kruskal-Wallis, P < .01 for both CGI improvement
and efficacy). For PGA, there was only a trend of
significance at T30 (P = .14). Indeed, for CGI, we
observed that 75% of patients had moderate
improvement with partial remission of symptoms in
the active group, while in the sham group 80% of
patients had only slight improvement at the end of
treatment.
tDCS-Induced Electric Current Fields: High-
Resolution Computational Models.—Brain current
flow (electric fields) though cortical and subcortical
structures was predicted using a high-resolution
Table 1.—Clinical and Demographic Characteristics at
Baseline
Active tDCS Sham tDCS
Number of subjects 8 5
Age (years, mean  SD) 45.2 (6.9) 45 (4.2)
Gender (number of females) 5 3
Duration of disease
(years, mean  SD)
27.8 (11.7) 31 (4.2)
Number of days in migraine
(per month, mean  SD)
28.4 (2) 29.5 (0.7)
Pain intensity
(VAS, mean  SD)
4.6 (2.1) 4.4 (1.9)
Length of migraine episodes
(hours, mean  SD)
8 (8.5) 12 (10.7)
There were no differences between active and sham tDCS
group (P > .05 for all the comparisons).
SD = standard deviation; tDCS = transcranial direct current
stimulation; VAS = visual analogue scale.
Table 2.—Adverse Effects Frequency
Active tDCS Sham tDCS Total
Headache 7 5 12
Neck pain 5 2 7
Tingling 4 2 6
Skin redness 2 4 6
Sleepiness 1 4 5
Scalp pain 1 1 2
Total 20 18 38
There were no differences in adverse effects frequency
between sham and active group (P = .46). Statistical analysis
for total adverse effects in each group.
tDCS = transcranial direct current stimulation.
Headache 1287
FE model of a representative adult male head (see
methods).
Outer Cortical Regions.—In the present study, we
identified clusters of electric current in regions
located anterior to the central sulcus. This increased
current flow was particularly intense in the dorsolat-
eral prefrontal cortex (DLPFC) (putative Brodmann
areas 8, 9, 9/46, and 46), with the highest current
density in the middle frontal gyri (putative Brodmann
area 46). In addition, significant peaks were also
shown in other areas, such as: non-primary motor
cortex (putative Brodmann area 6) and ventrolateral
prefrontal cortex (putative Brodmann areas 44, 45,
and 47/12), bilaterally. Elevated current density was
as well identified in the orbital frontal cortex on both
sides. Another noteworthy prediction is the increased
current density along the lateral (Sylvian) fissure,
especially on the right hemisphere (Fig. 3).
Inner (Sub)Cortical Regions.—Insula.—The analy-
sis of the current flow during tDCS showed a peak of
current density in the anterior insula, especially in the
anterior and middle short insular gyri, bilaterally.
There was another cluster of current in the posterior
insula, mostly in the anterior long insular gyrus on the
right side (Fig. 4).
Cingulate Cortex.—In the anterior regions of the
cingulate cortex, the current flow pattern displayed
increased density, including parts of the pregenual
anterior cingulate cortex (pACC) (putative Brod-
mann areas 32 and 24) and anterior mid-cingulate
cortex (aMCC) (putative Brodmann areas 32 and 24)
bilaterally. Furthermore, the peak of current density
was found on the right aMCC (putative Brodmann
area 32). Low current densities were demonstrated
along the posterior regions of the cingulate cortex,
and clusters with peaks of current flow could also be
seen in the PCC, particularly on the right side (puta-
tive Brodmann area 23) (Fig. 4).
Thalamus.—Our stimulations predicted current
flow in several regions of the thalamus associated with
pain. However, in the superior view, it was possible to
observe that the highest density occurred in the
posterior medial regions of the thalamus on the left
side, presumably affecting the ventral posteromedial
nucleus (VPM),the lateral posterior (LP),the pulvinar
(Pu) nuclei, and in the anterior medial and regions on
the right side, including dorsal medial (DM) and the
ventral anterior (VA) nuclei. Moreover, the inferior
view showed a peak current flow in both medial and
lateral areas of the thalamus, including areas of the
nucleus previously cited and other nuclei, such as the
centromedian (CMe),the parafascicular (PF),the ven-
trolateral (VL), and the LP (Fig. 4).
Brainstem.—Peaks of activation could be
observed in the cerebral peduncles, bilaterally.
These peaks of current extended medially to the
Fig 2.—Mean pain levels (as assessed by visual analogue scale) at baseline, T15, T30, F60, and F120 in the 2 groups of stimulation
(active and sham tDCS). Error bars indicate standard error of the mean.
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Fig 3.—tDCS current flow (electric field) through superficial brain structures. The top image illustrates tissue masks from the most
superficial areas (eg, skin, scalp, and outer cortical areas) to the inner structures (eg, insula, thalamus, cingulate gyrus, and
brainstem). The following sequence shows the electrodes montage, with the anode placed over the primary motor cortex (M1) and
the cathode over the supra-orbital cortex in different views. Current flow across outer cortex is represented by both electric field
magnitude (second column) and electric field component normal to the cortical surface (with direction; third column). The color
map depicts the current density, with red indicating high-current density and blue indicating low-current density. The peak of
current density is 0.25 V/m for outer cortical regions and 0.17 V/m for inner brain regions.
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interpeduncular fossa. The horizontal slices of the
midbrain revealed that the current flow reaches the
ventral tegmental area (VTA), mainly in the rostral
midbrain. In fact, it seems that this region received
the highest current flow in the midbrain. The current
flow also extended inferiorly to the pons but at
reduced levels. Nonetheless, the midbrain concen-
trated most parts of the brainstem activity (Fig. 4).
DISCUSSION
Our results demonstrate that tDCS applied over
motor (anodal) and orbitofrontal (cathode) cortices,
with sessions spread over the course of 1 month, can
decrease gradually the intensity of pain, length of the
chronic migraine episodes, and patients’ clinical
impression. Derived from our tDCS forward analysis,
these therapeutic effects may be associated with the
direct modulation of the pain neuromatrix. Previous
imaging and modeling studies have suggested tDCS
induces subcortical current flow;31-33 we illustrate that
significant current flow is induced across the brain by
our stimulation protocol, which extends from the
immediate target cortical regions to the even deeper
regions, including cingulate, insula, thalamus, and
brainstem.
Fig 4.—tDCS current flow (electric field) is represented in 4 different deep brain structures (cingulate gyrus, thalamus, insula, and
brainstem). The color coding depicts the current density, with red indicating high-current density and blue indicating low-current
density. Specific areas with peaks of current density (eg, ACC, MCC, dorsal medial, ventral anterior, ventral posteromedial nucleus,
lateral posterior, AI, and ventral tegmental area) are also identified. ACC = anterior cingulate cortex; MCC = mid-cingulate cortex;
AI = anterior insula.
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The analgesic effect we observed with the tDCS
montage targeting primary motor cortex (M1) cortex
supports the notion that the mechanisms of chronic
migraine are associated with plastic changes of
central structures, ie, central sensitization. This may
also be associated with a deficient inhibitory process,
as noticed with other chronic disorders with a similar
response to tDCS therapy.15,34,35 In this context, excit-
ability enhancing anodal tDCS of the primary motor
cortex might have as equivalent an effect as high-
frequency repetitive transcranial magnetic stimula-
tion (TMS) of normalizing the defective inhibitory
mechanisms in chronic pain.36 In addition, potentially
independent of M1 modulation, cathodal stimulation
over anterior prefrontal regions (supraorbital elec-
trode [SO]) also has analgesic effects via pain neuro-
matrix structures.22 For example, prominent current
peaks are predicted in the DLPFC and orbitofrontal
cortices. According to neuroimaging studies, these
areas play a relevant role in the mechanism of mood
disorders and chronic pain,37-39 including chronic
analgesic-overuse headache developing from epi-
sodic migraine.40 Based on those studies, it is possible
to suggest that our particular M1-SO tDCS electrode
montage may additionally alter the cortical excitabil-
ity in the anterior regions of the cerebral cortex
related to pain. Thus, the effects of tDCS need to be
seen as the combination of both electrodes as they
will determine where currents will be induced, as
investigated in this study.
Modeling predicated significant electric current
in neighboring inner cortical structures linked to
CM pathophysiology, as revealed in our results. For
instance, we demonstrated peak of current flow in the
anterior insula, bilaterally, especially in its rostral
parts (anterior and middle short gyri). Such effect of
tDCS stimulation in the rostral anterior insula might
help to explain the significant improvement of pain
intensity, length of migraine episodes, and CGI in
patients with chronic migraine, since the aforemen-
tioned area has a crucial importance in clinical and
emotional aspects of pain perception. Likewise, the
results of the current investigation suggest that tDCS
could potentially induce changes in the cortical excit-
ability of the anterior cingulate cortex, especially in
its anterior areas (pACC and aMCC). Indeed, previ-
ous functional (using positron emission tomography
[PET] and functional MRI) and structural (voxel-
based morphometry) studies demonstrated changes
in the cingulate cortex of migraine patients, mostly in
the anterior and midcingulate cortex (ACC and
MCC)41-45 but also in the posterior cingulate cortex
(pCC).41
An intriguing prediction of the present study is
that electric current produced by tDCS modulates
subcortical structures, including those of the pain neu-
romatrix. Bilateral thalamic activation has been fre-
quently demonstrated in PET and fMRI studies of
pain.38,39,46-53 In addition, it has been described that the
effects of both invasive motor cortex stimulation
(MCS) and noninvasive (tDCS; TMS) motor cortex
stimulations on pain relief depend on the projection
of fibers from the motor cortex to other structures
involved in pain processing, such as the thalamus and
brainstem nuclei.36,54 Our montage, placing the elec-
trode over the primary motor cortex, resulted in a
decrease of chronic migraine pain, and the results of
the current flow analysis showed a significant amount
of current reaching the VPM nucleus of the thalamus.
An interesting question here is whether pain modu-
lation induced by tDCS is due to direct effects of
currents reaching the thalamus through indirect
modulation, as shown by neuroimaging studies.55
Thus, one important point is that effects of tDCS
would lack specificity, as a broad neural area is
affected simultaneously during stimulation. It is
therefore not possible to make homotopic claims
when using tDCS, as recently discussed and shown in
a study using another technique of brain stimulation –
TMS.36
Structural and functional changes have been
described in the brainstem of patients with migraine.
Most changes were reported in the ventral and dorsal
midbrain, periaqueductal gray (PAG) area, dorsolat-
eral and dorsomedial pons,7,42,45,56 and also in the locus
coeruleus and raphe nuclei.57,58 Interestingly, a study
using PET scans to investigate changes in the regional
blood flow in the human brain during spontaneous
migraine attacks demonstrated increased blood flow
in several areas of the brain, including regions of the
cerebral hemispheres, cingulate, visual association
cortex, and brainstem. However, the brainstem was
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the only neural structure that still showed activation
even after a sumatriptan injection, which reduced
headache, phonophobia, and photophobia.45 Notwith-
standing changes in the inner parts of the brainstem
that could not be detected in this study, the strong
current activity seen in the cerebral peduncles, with
extension to the interpeduncular fossa and VTA, sug-
gests that the positive effect of tDCS in chronic pain
could be, at least in part, due to modulation of the
midbrain, which could include PAG, locus coeruleus,
and the raphe nuclei and VTA. The last region con-
tains dopaminergic neurons that project to amygdala
nucleus accumbens (NAcc), modulating their activi-
ties. Among the functions of the NAcc are reward,
placebo response, and pain.59,60
Although we show similar tDCS-induced analge-
sic effects in this study (when analyzing the follow-up)
as compared to other tDCS studies, there are some
important differences. First, we were not able to dem-
onstrate an immediate effect on the main clinical
outcome during treatment,but we showed a significant
improvement in the long-term evaluation (starting
after the period of stimulation up to 4 months after
treatment). Some reasons to explain this finding
should be considered here. For example, data variabil-
ity of pain scores might have decreased the power for
the analysis during stimulation;however, the data vari-
ability of follow-up is similar to the data variability
during treatment. The alternative explanation might
be due to our strategy of stimulation. The difference
with other pain studies is that we used a protocol for
tDCS in which it was applied every other day. This
might have reduced the initial efficacy of tDCS as
compared to daily tDCS sessions (as shown in a
depression study61), and therefore cumulative changes
developed more gradually. Finally, long-lasting
changes in plasticity, as observed in this study, have
been seen before in other conditions using tDCS.10,14,62
Even considering the potential delayed effects
observed in this study, it needs to be underscored that
repeated exposure may be needed in order to induce
lasting plastic changes promoting synaptic strength-
ening of the structures targeted. Actually, previous
studies have already demonstrated cumulative effects
of tDCS for diseases with different mechanisms such
as craving and motor recovery after stroke.63,64 In
agreement with these findings, the subjects in our
study had a long duration of disease (mean duration
of 28.6 years); therefore, it is conceivable that these
subjects have strong plastic changes in pain-related
neural networks. Hence, this might explain not only
the reduced effects during stimulation but also the
delayed effects after the end of stimulation.This study
has some limitations.We did not measure neurophysi-
ological data as to assess the mechanisms underlying
the effects of tDCS as the main study goal was to
collect preliminary data on the behavioral effects of
tDCS in CM. Further studies collecting neurophysi-
ological data can provide mechanistic insights on the
effects of tDCS in CM. Because our study was a proof
of principle study, thus the goal was to detect a signal
that the tDCS has an effect on pain in migraine, and
also to assess feasibility of this intervention and the
effects over time. Although our sample size of 13
patients could detect an effect size F of 0.67 (given 4
measurements and a correlation of 0.5 among mea-
surements), our study has a small sample size, and
therefore, we might have been underpowered to
detect changes in pain during treatment, and how
other variables influenced our results, for instance,
gender or medication effects on the outcome.
Finally, our tDCS computer modeling is based on
a single MRI-derived head model and is not patient
specific. We used this representative head model to
simulate our clinically used tDCS montage. Although
the precise distribution of current flow would be
effected by individual idiosyncratic anatomy and
electrode montage, significant current flow through
inner cortical and deep brain structures is expected
using most conventional tDCS montages, as sup-
ported by other modeling efforts32,33 and consistent
with imaging studies. Future studies may not only
consider the role of deeper structures in tDCS but
even optimize electrode montage to target one or
more regions of interest.65
This is a preliminary study aimed to evaluate in
an exploratory manner the clinical effects and neuro-
modulatory mechanisms of tDCS on CM patients.
Here, we demonstrated that tDCS has a delayed
effect on CM patients as they showed improvement
during the follow-up period as compared to sham
stimulation. In addition, this beneficial effect is asso-
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ciated with direct neuromodulation of cortical and
subcortical areas associated with the pain neuroma-
trix, and CM pathophysiology. Future research needs
to further explore other parameters of stimulation,
maintenance treatment, and the mechanisms associ-
ated with clinical improvements.
REFERENCES
1. Burstein R, Cutrer MF, Yarnitsky D. The develop-
ment of cutaneous allodynia during a migraine
attack clinical evidence for the sequential re-
cruitment of spinal and supraspinal nociceptive
neurons in migraine. Brain. 2000;123(Pt 8):1703-
1709.
2. Marcus DA. Central nervous system abnormalities
in migraine. Expert Opin Pharmacother. 2003;4:
1709-1715.
3. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ,
Bajwa ZH. An association between migraine and
cutaneous allodynia. Ann Neurol. 2000;47:614-624.
4. Marcus DA, Furman JM, Balaban CD. Motion sick-
ness in migraine sufferers. Expert Opin Pharmaco-
ther. 2005;6:2691-2697.
5. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous
allodynia in the migraine population. Ann Neurol.
2008;63:148-158.
6. Burstein R. Deconstructing migraine headache into
peripheral and central sensitization. Pain. 2001;89:
107-110.
7. Chiapparini L, Ferraro S, Grazzi L, Bussone G.
Neuroimaging in chronic migraine. Neurol Sci. 2010;
31(Suppl. 1):S19-S22.
8. DaSilva AF, Granziera C, Snyder J, Hadjikhani N.
Thickening in the somatosensory cortex of patients
with migraine. Neurology. 2007;69:1990-1995.
9. DaSilva AF, Granziera C, Tuch DS, Snyder J,
Vincent M, Hadjikhani N. Interictal alterations of
the trigeminal somatosensory pathway and peri-
aqueductal gray matter in migraine. Neuroreport.
2007;18:301-305.
10. Fregni F, Boggio PS, Lima MC, et al. A sham-
controlled, phase II trial of transcranial direct
current stimulation for the treatment of central pain
in traumatic spinal cord injury. Pain. 2006;122:197-
209.
11. Fregni F, Boggio PS, Nitsche MA, Rigonatti SP,
Pascual-Leone A. Cognitive effects of repeated ses-
sions of transcranial direct current stimulation in
patients with depression. Depress Anxiety. 2006;23:
482-484.
12. Mori F, Codeca C, Kusayanagi H, et al. Effects of
anodal transcranial direct current stimulation on
chronic neuropathic pain in patients with multiple
sclerosis. J Pain. 2010;11:436-442.
13. Roizenblatt S, Fregni F, Gimenez R, et al. Site-
specific effects of transcranial direct current.
stimulation on sleep and pain in fibromyalgia: A
randomized, sham-controlled study. Pain Pract.
2007;7:297-306.
14. Antal A, Terney D, Kuhnl S, Paulus W. Anodal
transcranial direct current stimulation of the motor
cortex ameliorates chronic pain and reduces short
intracortical inhibition. J Pain Symptom Manage.
2010;39:890-903.
15. Lefaucheur JP. New insights into the therapeutic
potential of non-invasive transcranial cortical stimu-
lation in chronic neuropathic pain. Pain. 2006;122:
11-13.
16. Gandiga PC, Hummel FC, Cohen LG. Transcranial
DC stimulation (tDCS): A tool for double-blind
sham-controlled clinical studies in brain stimulation.
Clin Neurophysiol. 2006;117:845-850.
17. Brunoni AR, Fregni F. Clinical trial design in non-
invasive brain stimulation psychiatric research. Int J
Methods Psychiatr Res. 2011;20:e19-e30.
18. Brunoni AR, Nitsche MA, Bolognini N, et al. Clini-
cal research with transcranial direct current stimu-
lation (tDCS): Challenges and future directions.
Brain Stimul. 2011; Apr 1. [Epub ahead of print]
19. Olesen J, Bousser MG, Diener HC, et al. New
appendix criteria open for a broader concept
of chronic migraine. Cephalalgia. 2006;26:742-
746.
20. Cardoso EF, Fregni F, Martins Maia F, et al. rTMS
treatment for depression in Parkinson’s disease
increases BOLD responses in the left prefrontal
cortex. Int J Neuropsychopharmacol. 2008;11:173-
183.
21. Fregni F, Gimenes R, Valle AC, et al. A randomized,
sham-controlled, proof of principle study of trans-
cranial direct current stimulation for the treatment
of pain in fibromyalgia. Arthritis Rheum. 2006;54:
3988-3998.
22. Mendonca ME, Santana MB, Baptista AF, et al.
Transcranial DC stimulation in fibromyalgia: Opti-
mized cortical target supported by high-resolution
computational models. J Pain. 2011;12:610-617.
Headache 1293
23. Fregni F, Freedman S, Pascual-Leone A. Recent
advances in the treatment of chronic pain with
non-invasive brain stimulation techniques. Lancet
Neurol. 2007;6:188-191.
24. Lefaucheur JP, Drouot X, Menard-Lefaucheur I,
et al. Neurogenic pain relief by repetitive transcra-
nial magnetic cortical stimulation depends on the
origin and the site of pain. J Neurol Neurosurg Psy-
chiatry. 2004;75:612-616.
25. Nitsche MA, Paulus W. Excitability changes induced
in the human motor cortex by weak transcranial
direct current stimulation. J Physiol. 2000;527:633-
639.
26. Paulus W. Transcranial direct current stimulation
(tDCS). Suppl Clin Neurophysiol. 2003;56:249-254.
27. Brunoni AR, Amadera J, Berbel B, Volz MS, Rizze-
rio BG, Fregni F. A systematic review on reporting
and assessment of adverse effects associated with
transcranial direct current stimulation. Int J Neuro-
psychopharmacol. 2011;14:1133-1145.
28. DaSilva AF, Volz MS, Bikson M, Fregni F. Electrode
positioning and montage in transcranial direct
current stimulation. J Vis Exp. 2011; May 23;(51). pii:
2744. doi: 10.3791/2744.
29. Datta A, Baker JM, Bikson M, Fridriksson J. Indi-
vidualized model predicts brain current flow during
transcranial direct-current stimulation treatment in
responsive stroke patient. Brain Stimul. 2011;4:169-
174.
30. Wagner T, Fregni F, Fecteau S, Grodzinsky A, Zahn
M, Pascual-Leone A. Transcranial direct current
stimulation: A computer-based human model study.
Neuroimage. 2007;35:1113-1124.
31. Lang N, Siebner HR, Ward NS, et al. How does
transcranial DC stimulation of the primary motor
cortex alter regional neuronal activity in the human
brain? Eur J Neurosci. 2005;22:495-504.
32. Sadleir RJ, Vannorsdall TD, Schretlen DJ, Gordon
B. Transcranial direct current stimulation (tDCS) in
a realistic head model. Neuroimage. 2010;51:1310-
1318.
33. Parazzini M, Fiocchi S, Rossi E, Paglialonga A,
Ravazzani P. Transcranial direct current stimulation:
Estimation of the electric field and of the current
density in an anatomical human head model. IEEE
Trans Biomed Eng. 2011;58:1773-1780.
34. Chadaide Z, Arlt S, Antal A, Nitsche MA, Lang N,
Paulus W. Transcranial direct current stimulation
reveals inhibitory deficiency in migraine. Cephalal-
gia. 2007;27:833-839.
35. Schwenkreis P, Janssen F, Rommel O, et al. Bilateral
motor cortex disinhibition in complex regional pain
syndrome (CRPS) type I of the hand. Neurology.
2003;61:515-519.
36. Lefaucheur JP, Hatem S, Nineb A, et al. Somato-
topic organization of the analgesic effects of motor
cortex rTMS in neuropathic pain. Neurology.
2006;67:1998-2004.
37. Grachev ID, Ramachandran TS, Thomas PS, Szev-
erenyi NM, Fredrickson BE. Association between
dorsolateral prefrontal N-acetyl aspartate and
depression in chronic back pain: An in vivo proton
magnetic resonance spectroscopy study. J Neural
Transm. 2003;110:287-312.
38. Hsieh JC, Belfrage M, Stone-Elander S, Hansson P,
Ingvar M. Central representation of chronic ongoing
neuropathic pain studied by positron emission
tomography. Pain. 1995;63:225-236.
39. Peyron R, Garcia-Larrea L, Gregoire MC, et al.
Allodynia after lateral-medullary (Wallenberg)
infarct. A PET study. Brain. 1998;121:345-356.
40. Fumal A, Laureys S, Di Clemente L, et al. Orbito-
frontal cortex involvement in chronic analgesic-
overuse headache evolving from episodic migraine.
Brain. 2006;129:543-550.
41. Kim JH, Suh SI, Seol HY, et al. Regional grey matter
changes in patients with migraine: A voxel-based
morphometry study. Cephalalgia. 2008;28:598-604.
42. May A. New insights into headache: An update on
functional and structural imaging findings. Nat Rev
Neurol. 2009;5:199-209.
43. Schmidt-Wilcke T, Ganssbauer S, Neuner T,
Bogdahn U, May A. Subtle grey matter changes
between migraine patients and healthy controls.
Cephalalgia. 2008;28:1-4.
44. Valfre W, Rainero I, Bergui M, Pinessi L. Voxel-
based morphometry reveals gray matter abnormali-
ties in migraine. Headache. 2008;48:109-117.
45. Weiller C, May A, Limmroth V, et al. Brain stem
activation in spontaneous human migraine attacks.
Nat Med. 1995;1:658-660.
46. Casey KL, Minoshima S, Morrow TJ, Koeppe RA.
Comparison of human cerebral activation pattern
during cutaneous warmth, heat pain, and deep cold
pain. J Neurophysiol. 1996;76:571-581.
47. Derbyshire SW, Jones AK, Devani P, et al. Cerebral
responses to pain in patients with atypical facial
pain measured by positron emission tomography.
J Neurol Neurosurg Psychiatry. 1994;57:1166-
1172.
1294 September 2012
48. Iadarola MJ, Max MB, Berman KF, et al. Unilateral
decrease in thalamic activity observed with positron
emission tomography in patients with chronic neu-
ropathic pain. Pain. 1995;63:55-64.
49. May A, Bahra A, Buchel C, Frackowiak RS,
Goadsby PJ. Hypothalamic activation in cluster
headache attacks. Lancet. 1998;352:275-278.
50. Petrovic P, Ingvar M, Stone-Elander S, Petersson
KM, Hansson P. A PET activation study of dynamic
mechanical allodynia in patients with mononeur-
opathy. Pain. 1999;83:459-470.
51. Rocca MA, Valsasina P, Absinta M, et al. Central
nervous system dysregulation extends beyond the
pain-matrix network in cluster headache. Cephalal-
gia. 2010;30:1383-1391.
52. Schweinhardt P, Glynn C, Brooks J, et al. An fMRI
study of cerebral processing of brush-evoked allo-
dynia in neuropathic pain patients. Neuroimage.
2006;32:256-265.
53. Vogt BA, Derbyshire S, Jones AK. Pain processing
in four regions of human cingulate cortex localized
with co-registered PET and MR imaging. Eur J Neu-
rosci. 1996;8:1461-1473.
54. Drouot X, Nguyen JP, Peschanski M, Lefaucheur JP.
The antalgic efficacy of chronic motor cortex stimu-
lation is related to sensory changes in the painful
zone. Brain. 2002;125:1660-1664.
55. Lang N, Nitsche MA, Paulus W, Rothwell JC,
Lemon RN. Effects of transcranial direct current
stimulation over the human motor cortex on corti-
cospinal and transcallosal excitability. Exp Brain
Res. 2004;156:439-443.
56. Rocca MA, Ceccarelli A, Falini A, et al. Brain gray
matter changes in migraine patients with T2-
visible lesions: A 3-T MRI study. Stroke. 2006;37:
1765-1770.
57. May A. The window into headache research:
What have we learned from functional and
structural neuroimaging. Schmerz. 2010;24:130-
136.
58. Raskin NH, Hosobuchi Y, Lamb S. Headache may
arise from perturbation of brain. Headache. 1987;27:
416-420.
59. Becerra L, Borsook D. Signal valence in the nucleus
accumbens to pain onset and offset. Eur J Pain. 2008;
12:866-869.
60. Nolte J, Sundsten JW. The Human Brain: An Intro-
duction to Its Functional Anatomy, 5th edn. St. Louis,
MO: Mosby; 2001.
61. Loo CK, Sachdev P, Martin D, et al. A double-blind,
sham-controlled trial of transcranial direct current
stimulation for the treatment of depression. Int J
Neuropsychopharmacol. 2010;13:61-69.
62. Quartarone A, Morgante F, Bagnato S, et al. Long
lasting effects of transcranial direct current stimula-
tion on motor imagery. Neuroreport. 2004;15:1287-
1291.
63. Boggio PS, Liguori P, Sultani N, Rezende L, Fecteau
S, Fregni F. Cumulative priming effects of cortical
stimulation on smoking cue-induced craving. Neuro-
sci Lett. 2009;463:82-86.
64. Boggio PS, Nunes A, Rigonatti SP, Nitsche MA,
Pascual-Leone A, Fregni F. Repeated sessions of
noninvasive brain DC stimulation is associated with
motor function improvement in stroke patients.
Restor Neurol Neurosci. 2007;25:123-129.
65. Dmochowski JP, Datta A, Bikson M, Su Y,
Parra LC. Optimized multi-electrode stimulation
increases focality and intensity at target. J Neural
Eng. 2011; Aug;8(4):046011. Epub 2011 Jun 10.
SUPPORTING INFORMATION
Additional supporting information may be found in the
online version of this article:
Please note: Wiley-Blackwell is not responsible for the
content or functionality of any supporting materials sup-
plied by the authors. Any queries (other than missing
material) should be directed to the corresponding
author for the article.
Headache 1295
